Bosh sahifaTMO • NYSE
add
Thermo Fisher Scientific
423,55 $
Seans yopilganidan keyin:(0,00%)0,00
423,55 $
Yopilgan:2-may, 16:29:42 (GMT-4) · USD · NYSE · Ogohlantirish
Yopilish kursi
419,89 $
Kunlik diapazon
422,42 $ - 431,44 $
Yillik diapazon
409,85 $ - 627,88 $
Bozor kapitalizatsiyasi
159,89 mlrd USD
Oʻrtacha hajm
2,64 mln
Narx/foyda
24,85
Dividend daromadliligi
0,41%
Asosiy maydon
NYSE
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 10,36 mlrd | 0,18% |
Joriy xarajat | 2,48 mlrd | -0,68% |
Sof foyda | 1,51 mlrd | 13,48% |
Sof foyda marjasi | 14,54 | 13,24% |
Har bir ulushga tushum | 5,15 | 0,78% |
EBITDA | 2,55 mlrd | -0,55% |
Amaldagi soliq stavkasi | 5,92% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 5,95 mlrd | -17,97% |
Jami aktivlari | 99,04 mlrd | 2,00% |
Jami passivlari | 49,56 mlrd | -3,72% |
Umumiy kapital | 49,48 mlrd | — |
Tarqatilgan aksiyalar | 378,00 mln | — |
Narxi/balansdagi bahosi | 3,22 | — |
Aktivlardan daromad | 4,69% | — |
Kapitaldan daromad | 5,54% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 1,51 mlrd | 13,48% |
Operatsiyalardan naqd pul | 723,00 mln | -42,21% |
Sarmoyadan naqd pul | -527,00 mln | 74,04% |
Moliyadan naqd pul | -102,00 mln | 94,40% |
Naqd pulning sof oʻzgarishi | 132,00 mln | 105,12% |
Boʻsh pul | -60,75 mln | -106,92% |
Haqida
Thermo Fisher Scientific Inc. is an American life science and clinical research company. It is a global supplier of analytical instruments, clinical development solutions, specialty diagnostics, laboratory, pharmaceutical and biotechnology services. Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006. Thermo Fisher Scientific has acquired other reagent, consumable, instrumentation, and service providers, including Life Technologies Corporation, Alfa Aesar, Affymetrix, FEI Company, BD Advanced Bioprocessing, and PPD.
As of 2023, the company had a market capitalization of $202 billion. It ranked 97th on the Fortune 500 list based on its 2022 annual revenue of US$44.92 billion. Wikipedia
Tashkil etilgan
1956
Sayt
Xodimlar soni
125 000
